Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Tata Stl 426.60 1.32
Hindalco 144.70 0.00
Bhel 189.30 1.42
Larsen & 1377.30 2.48
Wipro Lt 525.00 1.19
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Elder Pharmaceuticals Limited
Elder Pharmaceuticals Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:532322NSE:ELDERPHARMBloomberg:ELDP@INReuters:ELDP.BO
Market Lot: 1Face Value: 10ISIN Demat: INE975A01015
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
13-DEC-13 Torrent Pharmaceuticals announced that it has entered into a definitive binding agreement with Elder Pharmaceuticals to acquire its branded domestic formulations business in India and Nepal for a consideration of about Rs 20 billion. 07-NOV-13 Elder Pharmaceuticals clarified that the default is only to the tune of Rs 100 million and not Rs 2.61 billion. The error in reporting was corrected by Economic Times, Mumbai Edition today. 11...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Default is only of Rs 100 mn and not Rs 2,610 mn, clarifies Elder Pharma   -IRIS 07-Nov-13
Previous

More


Brief Financials (in Rs. Mn.)Detailed Quarterly
Period ending (months)31-Dec-2013(6)30-Jun-2013 (15)31-Mar-2012 (12)
Net sales 2896.9412299.269818.91
Other Income74.49262.1884.89
Total Income2971.4312561.449903.80
Cost of goods sold2237.189640.277725.68
OPBDIT734.252921.172178.12
PAT-175.38937.38856.42
Gross Block---
Equity capital205.37205.37205.37
EPS (Rs.)-45.6441.70
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-5.54 - 12.987.15 - 10.43
Debt / Equity (x)---
Operating margin (% of OI)24.723.322.0
Net margin (% of OI)-5.9 7.5 8.6
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Elder House
Plot No C - 9, Dalia Industrial Estate
Off Veera Desai Road
Andheri (West)
Mumbai
Maharashtra-400 053
PHONE
(022) 2673 0058
FAX
(022) 2673 0051
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer